Mural Oncology (NASDAQ:MURA – Get Free Report) had its target price lowered by equities researchers at HC Wainwright from $18 ...

Stock analysts at HC Wainwright decreased their Q1 2025 earnings per share estimates for shares of Rhythm Pharmaceuticals in ...

Fintel reports that on March 27, 2025, HC Wainwright & Co. initiated coverage of RenovoRx (NasdaqCM:RNXT) with a Buy ...

H.C. Wainwright lowered the firm’s price target on Bitfarms (BITF) to $3.50 from $4 and keeps a Buy rating on the shares. The firm also added ...

H.C. Wainwright analyst Joseph Pantginis lowered the firm’s price target on PDS Biotechnology (PDSB) to $13 from $21 and keeps a Buy rating on ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a ...

SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the ...

Diagnostics' Q4 2024 earnings insights, FDA resubmissions, TB & HPV test pipelines, and international market growth plans.

CEO Steven Rossi emphasized that fiscal year 2024 was a transformative period for Worksport, with net sales reaching $8.4 million, representing a 455% increase from 2023. This growth was primarily ...

CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) Q4 2024 Earnings Call Transcript March 26, 2025 CollPlant Biotechnologies Ltd.

Shares of PDS Biotechnology Corporation (PDSB) drew investor attention on Thursday after the company reported ...